Navigation Links
Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation
Date:5/19/2013

New York, New York (PRWEB) May 19, 2013

The Pradaxa lawyers at Bernstein Liebhard LLP note that a Case Management Conference was recently convened for hundreds of Pradaxa bleeding lawsuits pending in a federal multidistrict litigation now underway in U.S. District Court, Southern District of Illinois. According to Minutes posted on the Court’s website on May 14th, the Conference addressed the status of depositions and pending motions. It was also reported during the Conference that Defendants submitted a list of early trial eligible cases to the Court and Plaintiffs’ co-lead counsel last month, and that the parties have revised and finalized the list. ( In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“We are pleased to see the federal Pradaxa litigation moving forward. We continue to receive inquiries from Pradaxa users who have allegedly suffered frightening episodes of internal bleeding while being treated with this blood thinner,” said Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm’s Pradaxa lawyers are currently offering free legal evaluations to alleged victims of Pradaxa bleeding.

Pradaxa Side Effect Lawsuits
Court records indicate that 711 Pradaxa lawsuits are currently pending in the Southern District of Illinois. All of the lawsuits allege Boehringer Ingelheim failed to adequately warn that there is no readily-available antidote for Pradaxa bleeding. The first trial in the litigation is scheduled to start in September 2014.

Pradaxa was approved for sale by the U.S. Food & Drug Administration (FDA) in October 2010 to prevent strokes in people with atrial fibrillation, and was supposed to provide an improved alternative to warfarin. But according to a report published by Bloomberg.com in December, regulators in several countries have issued Pradaxa bleeding alerts since the drug’s launch. One real danger is the fact that there exists no readily-available antidote for internal bleeding, a potentially life-threatening Pradaxa side effect. *

On May 1st, the Journal of Neurosurgery published a study that showed head trauma victims were more likely to die from brain bleeding if they had been using Pradaxa compared to those taking warfarin. The authors of the research said that the absence of an effective reversal agent could account for the higher death rate among Pradaxa patients.** In January, an analysis of FDA hemorrhage cases published in the Institute for Safe Medication Practice’s QuarterWatch report revealed Pradaxa bleeding was 5 times more likely to have a fatal outcome compared to warfarin bleeding.***

Victims of serious Pradaxa side effects may be eligible to collect compensation for their medical bills, lost wages, pain and suffering and more. Additional information regarding Pradaxa lawsuits is available at Bernstein Liebhard LLP’s website. To arrange for a free legal consultation with a Pradaxa lawyer, please call 800-511-5092.

*bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html
**thejns.org/doi/pdf/10.3171/2013.3.JNS12503
***ismp.org/quarterwatch/pdfs/2012Q2.pdf

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.pradaxalawsuithelp.com/

Read the full story at http://www.prweb.com/releases/pradaxa-bleeding/pradaxa-lawyer/prweb10747155.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pradaxa Lawsuit Update: Bernstein Liebhard LLP Notes Filings in Federal Pradaxa Litigation Surpass 700
2. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
3. Rottenstein Law Group LLP Responds to Study Linking Pradaxa Side Effects with Potential Mortality Risks
4. Update on Pradaxa Internal Bleeding Problem Allegations Lawsuits; Resource4thePeople Reports Bellwether Trial Dates Scheduled
5. Pradaxa Lawyers at Bernstein Liebhard LLP Comment on New Study Highlighting the Risk of Pradaxa Brain Bleeding
6. DrugRisks Update: Warning Added to Pradaxa For Blood Condition
7. Pradaxa Lawsuits Move Forward, With Scheduling of Next Status Conference in Federal Pradaxa Litigation, Bernstein Liebhard LLP Reports
8. DrugRisk Update: Court Asks for Pradaxa Lawsuit Test Cases
9. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
10. DrugRisk Adds Study Showing Pradaxa May Increase Viral Infection Risk
11. 2013 Cases Involving Pradaxa Internal Bleeding Problem Allegations Now Being Investigated by Resource4thePeople Lawyers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: ... and sells medical devices and wearable sleep respiratory products ... cooperation agreement with Hongyuan Supply Chain Management Co., Ltd. ... 20, 2016, to develop Dehaier,s new Internet medical technology ... will leverage Hongyuan Supply Chain,s sales platform to reach ...
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
Breaking Medicine Technology: